Nitro fatty acids (NO 2 -FAs) are biologically active compounds produced from the reaction of unsaturated fatty acids with reactive nitrogen species (RNS). Due to their electrophilic nature, these endogenously produced metabolites can react with nucleophilic targets, producing a spectrum of modulatory and protective effects. Determination of NO 2 -FAs in biological samples is challenging due to their low nanomolar to picomolar endogenous concentrations, indistinct metabolism, and distribution in many tissues and biofluids. Several attempts have been made to develop precise, standardized, and efficient methodologies for assessing physiological and pathophysiological processes to overcome the difficulties associated with their measurement. This review discusses those approaches utilizing liquid chromatography tandem mass spectrometry (LC‒MS/MS) and gas chromatography tandem mass spectrometry (GC‒MS/MS) for the quantification of NO 2 -FAs, in addition to a summary of their laboratory synthesis and extraction from biological samples. Clinical associations with different pathological conditions, including hyperlipidaemia, cardiac ischemia and herpes simplex type 2 viral infection (HSV-2), are also discussed.
Keyphrases
- gas chromatography
- solid phase extraction
- tandem mass spectrometry
- liquid chromatography tandem mass spectrometry
- fatty acid
- simultaneous determination
- ultra high performance liquid chromatography
- liquid chromatography
- high performance liquid chromatography
- ms ms
- molecularly imprinted
- mass spectrometry
- high resolution mass spectrometry
- gas chromatography mass spectrometry
- high resolution
- healthcare
- gene expression
- public health
- health information
- mental health
- heart failure
- herpes simplex virus
- left ventricular
- climate change